David Mack
Gründer bei PMV PHARMACEUTICALS, INC.
Vermögen: 1 Mio $ am 30.04.2024
Aktive Beziehungen
| Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
|---|---|---|---|---|
| Michael Carulli | M | 74 | 4 Jahre | |
| Arnold Levine | M | 84 | 11 Jahre | |
| Kirsten Flowers | F | 49 | 2 Jahre | |
| Wei Wu He | M | 59 |
Intradigm Corp.
 Intradigm Corp. Pharmaceuticals: MajorHealth Technology Intradigm Corp. develops drugs and therapies. Its RNAi therapeutic platform comprised of proprietary delivery technologies, potent siRNA sequences and innovative siRNA structural features. The company was founded by Puthupparampil Scaria, Martin C. Woodle, Wei-Wu He and Patrick Y. Lu in 2000 and is headquartered in Palo Alto, CA. | 24 Jahre |
| James Topper | M | 62 |
Intradigm Corp.
Intradigm Corp. Pharmaceuticals: MajorHealth Technology Intradigm Corp. develops drugs and therapies. Its RNAi therapeutic platform comprised of proprietary delivery technologies, potent siRNA sequences and innovative siRNA structural features. The company was founded by Puthupparampil Scaria, Martin C. Woodle, Wei-Wu He and Patrick Y. Lu in 2000 and is headquartered in Palo Alto, CA. | 18 Jahre |
| Ilya Ravkin | M | - |
Vitra Bioscience, Inc.
 Vitra Bioscience, Inc. Pharmaceuticals: OtherHealth Technology Vitra Bioscience, Inc. develops technologies for biological research and drug discovery. Its technology includes cellcard system and cellplex assays which facilitate multiple cell-types and parameters to be evaluated. The cellcard imaging system collects images and then analyzed with proprietary software. The company was founded by Simon Goldbard and is headquartered in Mountain View, CA. | - |
| Richard Heyman | M | 66 | 4 Jahre | |
| Timothy J. Smith | M | - | 3 Jahre | |
| Deepika Jalota | M | 48 | 5 Jahre | |
| Charles Baum | M | 65 | 3 Jahre | |
| Robert Ticktin | M | 62 | - | |
| Laurie Stelzer | F | 56 | 4 Jahre | |
| Lev J. Leytes | M | - |
Vitra Bioscience, Inc.
Vitra Bioscience, Inc. Pharmaceuticals: OtherHealth Technology Vitra Bioscience, Inc. develops technologies for biological research and drug discovery. Its technology includes cellcard system and cellplex assays which facilitate multiple cell-types and parameters to be evaluated. The cellcard imaging system collects images and then analyzed with proprietary software. The company was founded by Simon Goldbard and is headquartered in Mountain View, CA. | - |
| Shibu Sleeba | M | - | 4 Jahre | |
| Crystal Zuckerman | F | - | 4 Jahre | |
| Laura De Leon | F | - | 5 Jahre | |
| Gary Becker | M | - |
The University of Chicago
| 32 Jahre |
| Binh Vu | M | 56 | - | |
| Alain A. Couder | M | 78 |
Vitra Bioscience, Inc.
Vitra Bioscience, Inc. Pharmaceuticals: OtherHealth Technology Vitra Bioscience, Inc. develops technologies for biological research and drug discovery. Its technology includes cellcard system and cellplex assays which facilitate multiple cell-types and parameters to be evaluated. The cellcard imaging system collects images and then analyzed with proprietary software. The company was founded by Simon Goldbard and is headquartered in Mountain View, CA. | - |
| Michael Riley | M | - |
Intradigm Corp.
Intradigm Corp. Pharmaceuticals: MajorHealth Technology Intradigm Corp. develops drugs and therapies. Its RNAi therapeutic platform comprised of proprietary delivery technologies, potent siRNA sequences and innovative siRNA structural features. The company was founded by Puthupparampil Scaria, Martin C. Woodle, Wei-Wu He and Patrick Y. Lu in 2000 and is headquartered in Palo Alto, CA. | 18 Jahre |
| Bryan Dunnivant | M | - |
Intradigm Corp.
Intradigm Corp. Pharmaceuticals: MajorHealth Technology Intradigm Corp. develops drugs and therapies. Its RNAi therapeutic platform comprised of proprietary delivery technologies, potent siRNA sequences and innovative siRNA structural features. The company was founded by Puthupparampil Scaria, Martin C. Woodle, Wei-Wu He and Patrick Y. Lu in 2000 and is headquartered in Palo Alto, CA. | 16 Jahre |
| Simon Goldbard | M | - |
Vitra Bioscience, Inc.
Vitra Bioscience, Inc. Pharmaceuticals: OtherHealth Technology Vitra Bioscience, Inc. develops technologies for biological research and drug discovery. Its technology includes cellcard system and cellplex assays which facilitate multiple cell-types and parameters to be evaluated. The cellcard imaging system collects images and then analyzed with proprietary software. The company was founded by Simon Goldbard and is headquartered in Mountain View, CA. | - |
| Carol Gallagher | M | 59 | 2 Jahre | |
| Marc Fellous | M | - | 2 Jahre |
Beziehungs-Chart
Beziehungen zu mehreren Unternehmen
Ehemalige Beziehungen
| Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
|---|---|---|---|---|
| Richard Rubino | M | 66 | 9 Jahre | |
| Thomas J. van Haarlem | M | - | 8 Jahre | |
| Geoff Duyk | M | 64 | 12 Jahre | |
| Jennifer Lew | F | 51 | 6 Jahre | |
| Ahmad Mortazavi | M | 53 | 6 Jahre | |
| Casey C. Kopczynski | M | 62 | 17 Jahre | |
| Philip Haworth | M | 68 |
Intradigm Corp.
Intradigm Corp. Pharmaceuticals: MajorHealth Technology Intradigm Corp. develops drugs and therapies. Its RNAi therapeutic platform comprised of proprietary delivery technologies, potent siRNA sequences and innovative siRNA structural features. The company was founded by Puthupparampil Scaria, Martin C. Woodle, Wei-Wu He and Patrick Y. Lu in 2000 and is headquartered in Palo Alto, CA. | 1 Jahre |
| Mohammad Azab | M | 68 |
Intradigm Corp.
Intradigm Corp. Pharmaceuticals: MajorHealth Technology Intradigm Corp. develops drugs and therapies. Its RNAi therapeutic platform comprised of proprietary delivery technologies, potent siRNA sequences and innovative siRNA structural features. The company was founded by Puthupparampil Scaria, Martin C. Woodle, Wei-Wu He and Patrick Y. Lu in 2000 and is headquartered in Palo Alto, CA. | 4 Jahre |
| Catherine Kleinmuntz | M | - |
The University of Chicago
| - |
| Stephen T. Isaacs | M | 75 | 12 Jahre | |
| Joseph Werne | M | - |
The University of Chicago
| 6 Jahre |
| Jia Huey Cheng | F | 48 | 1 Jahre | |
| Tim Freeborn | M | - | 4 Jahre | |
| David L. Epstein | M | - | - | |
| Winston Kung | M | 48 | 7 Jahre | |
| Federico L. Kaune | M | - |
The University of Chicago
| 4 Jahre |
| Daniel J. Young | M | - |
The University of Chicago
| 4 Jahre |
| Stephen M. McConnell | M | - |
The University of Chicago
| 1 Jahre |
| Eric J. Toone | M | - | - | |
| Janet L. Conway | M | 74 | 9 Jahre | |
| Xiao Dong Yang | M | 64 |
Intradigm Corp.
Intradigm Corp. Pharmaceuticals: MajorHealth Technology Intradigm Corp. develops drugs and therapies. Its RNAi therapeutic platform comprised of proprietary delivery technologies, potent siRNA sequences and innovative siRNA structural features. The company was founded by Puthupparampil Scaria, Martin C. Woodle, Wei-Wu He and Patrick Y. Lu in 2000 and is headquartered in Palo Alto, CA. | 1 Jahre |
| Mark Nydam | M | - |
The University of Chicago
| 3 Jahre |
| Stephen Sherwin | M | 75 | 5 Jahre | |
| Alberto Ramos | M | - |
The University of Chicago
| 5 Jahre |
| Rachael S. Wexler | F | - |
The University of Chicago
| 4 Jahre |
| Anthony David Sedgwick | M | 68 | 2 Jahre | |
| Bill Bergman | M | - |
The University of Chicago
| 3 Jahre |
| Ed J. Powers | M | - |
The University of Chicago
| 3 Jahre |
| Michael Khan | M | - | 4 Jahre | |
| Jeremy Feigelson | M | - |
The University of Chicago
| 3 Jahre |
| Nancy Kaplan | F | - | 11 Jahre | |
| Thilo Schroeder | M | 42 | 3 Jahre | |
| Stanley Ryan | M | 62 |
The University of Chicago
| 2 Jahre |
| Mark Phelan | M | 55 |
The University of Chicago
| 3 Jahre |
| Anand Mehra | M | 48 | - | |
| Igal Litovsky | M | - |
The University of Chicago
| 4 Jahre |
| Max Herrmann | M | - | 2 Jahre | |
| Francis McCormick | M | 73 | 9 Jahre | |
| Frank Karbe | M | 55 | 1 Jahre | |
| Frank D. Gordon | M | - |
The University of Chicago
| 4 Jahre |
| William C. Stern | M | 60 |
The University of Chicago
| 3 Jahre |
| Dennis J. Henner | M | 72 | 4 Jahre | |
| Murray Goldberg | M | 79 | 7 Jahre | |
| Jeremy Curnock-Cook | M | 75 | - | |
| Giorgio de Santis | M | - |
The University of Chicago
| 5 Jahre |
| James Welch | M | 66 | - | |
| Vicente J. Anido | M | 71 | 8 Jahre | |
| William G. Kachioff | M | 58 | - | |
| Iain Ross | M | 71 | 6 Jahre | |
| John Melvyn Davies | M | 68 | 14 Jahre | |
| Tim Anderson | M | - |
The University of Chicago
| 5 Jahre |
| Thomas A. Mitro | M | 66 | 9 Jahre | |
| Catherine Stehman-Breen | M | 61 |
The University of Chicago
| 3 Jahre |
| Gerald D. Cagle | M | 79 | 9 Jahre | |
| Stephanie O'Brien | F | 65 | 9 Jahre | |
| Peter Thompson | M | 64 | 8 Jahre | |
| Thomas Christély | M | - | - | |
| Phillipa White | F | - |
The University of Chicago
| 4 Jahre |
| Eddie Allen | M | - |
The University of Chicago
| 6 Jahre |
| Samir Chandrakant Patel | M | 62 |
The University of Chicago
| - |
| Chris LeMasters | M | - |
The University of Chicago
| 2 Jahre |
| John F. Haley | M | - |
The University of Chicago
| 4 Jahre |
| John DeLoche | M | - |
The University of Chicago
| 4 Jahre |
| Russell M. Wofford | M | - |
The University of Chicago
| 3 Jahre |
| Nick Trikolas | M | - |
The University of Chicago
| 2 Jahre |
| David Cobey | M | - |
The University of Chicago
| 2 Jahre |
| Shelby Scott Gaille | M | 54 |
The University of Chicago
| 3 Jahre |
| Jill Smart | F | 64 |
The University of Chicago
| 2 Jahre |
| Makoto Sumino | M | - |
The University of Chicago
| 2 Jahre |
| Bonnie A. Barsamian | F | - |
The University of Chicago
| 3 Jahre |
| Doug Jackman | M | 58 |
The University of Chicago
| 4 Jahre |
| Garrett A. DeVries | M | - |
The University of Chicago
| 3 Jahre |
| James P. Gordon | M | - |
The University of Chicago
| 2 Jahre |
| John Willmoth | M | - |
The University of Chicago
| 3 Jahre |
| Paul Slaats | M | - |
The University of Chicago
| 3 Jahre |
| Joe Boushelle | M | - |
The University of Chicago
| 4 Jahre |
Statistik
| Land | Beziehungen | % des Gesamten |
|---|---|---|
| Vereinigte Staaten | 90 | 90,00% |
| Vereinigtes Königreich | 13 | 13,00% |
Alter der Beziehungen
Aktive
Vergangene
Herr
Frau
Aufsichtsräte
Führungskräfte
Ursprung der Beziehungen
- Börse
- Insiders
- David Mack
- Persönliches Netzwerk
